2013
DOI: 10.1097/gme.0b013e3182843aad
|View full text |Cite
|
Sign up to set email alerts
|

Timing hypothesis for postmenopausal hormone therapy

Abstract: In this nonhuman primate trial, treatment with BZA alone, CEE alone, and combined BZA and CEE does not have significant effects on plasma lipid profiles. CEE markedly inhibits the progression and complications of both coronary and iliac artery atheroscleroses. BZA has no adverse effects on atherosclerosis but attenuates the atheroprotective effects of CEE.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

5
84
2
10

Year Published

2015
2015
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 135 publications
(101 citation statements)
references
References 83 publications
5
84
2
10
Order By: Relevance
“…17,18 Hence, the vasculature could also be more responsive to exercise training during this period. In support of this suggestion, the vascular response to infusion of epoprostenol and acetylcholine increased with exercise training in the postmenopausal women and this effect of training was not different from that of the premenopausal women.…”
Section: Hypertensionmentioning
confidence: 99%
See 1 more Smart Citation
“…17,18 Hence, the vasculature could also be more responsive to exercise training during this period. In support of this suggestion, the vascular response to infusion of epoprostenol and acetylcholine increased with exercise training in the postmenopausal women and this effect of training was not different from that of the premenopausal women.…”
Section: Hypertensionmentioning
confidence: 99%
“…Along these lines, the beneficial effects of estrogen supplementation in terms of atherosclerosis and cardiovascular disease are most pronounced during the peri-and early postmenopausal years when estrogen receptors (ERs) or other compensatory mechanisms may function. 17,18 To what extent the beneficial effects of exercise training on vascular function are preserved in the early postmenopausal phase is currently not known.…”
Section: Hypertensionmentioning
confidence: 99%
“…ЖСС, оцениваемая по СРПВ, является незави-симым предвестником общей смерти от ССЗ, фатальных и нефатальных коронарных осложнений, фатальных ин-сультов у пациентов с АГ, сахарным диабетом (СД) 2-го типа, хронической почечной недостаточностью (ХПН), пожилых лиц, а также в общей популяции [23].…”
Section: апоптоз и старениеunclassified
“…This notion was supported by experimental studies in monkeys in which hormone therapy was effective in slowing atherosclerosis when administered soon after surgical menopause whereas the benefit was lost if therapy was delayed until plaques had developed (226) This prompted further analyses of the combined data from both the observational and clinical trial arms of WHI according to age and years since menopause.…”
Section: Hormone Therapy and Cardiovascular Diseasementioning
confidence: 82%
“…The National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study which followed 654 postmenopausal for a median of The timing hypothesis remains controversial; however the protective effect of estrogens in perimenopausal or early postmenopausal women for the treatment of menopausal symptoms which may in turn slow down the progression of atherosclerosis seems convincing (226). Taken together, these observations seem plausible since newly menopausal women have fewer thrombotic modifications to their vasculature due to healthier vascular endothelium which is also more resistant to thrombosis (96), and thereby might benefit from the protective effect of estrogen.…”
Section: Hormone Therapy and Cardiovascular Diseasementioning
confidence: 99%